The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
85173113 8517311 3 F 20100522 20160726 20120417 20160728 EXP US-ROCHE-772118 ROCHE 58.14 YR M Y 0.00000 20160728 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
85173113 8517311 1 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1000 MG/M2, DAYS1,8,15 0 5180 MG
85173113 8517311 2 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 3 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 4 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 5 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 6 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 7 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 8 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 5180 MG
85173113 8517311 9 C OXYCODONE OXYCODONE 1 0
85173113 8517311 10 PS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 11 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 12 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 13 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 14 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 15 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD
85173113 8517311 16 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
85173113 8517311 1 Pancreatic carcinoma metastatic
85173113 8517311 10 Pancreatic carcinoma metastatic

Outcome of event

Event ID CASEID OUTC COD
85173113 8517311 HO
85173113 8517311 OT
85173113 8517311 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
85173113 8517311 Ascites
85173113 8517311 Constipation
85173113 8517311 Death
85173113 8517311 Dehydration
85173113 8517311 Hyponatraemia
85173113 8517311 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
85173113 8517311 8 20100523 20100527 0
85173113 8517311 10 20091016 0
85173113 8517311 11 20091113 0
85173113 8517311 12 20091211 0
85173113 8517311 13 20100108 0
85173113 8517311 14 20100216 0
85173113 8517311 15 20100316 0
85173113 8517311 16 20100420 20100523 0